Detalles de la búsqueda
1.
Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA.
Blood;
143(6): 522-534, 2024 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37946299
2.
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma.
N Engl J Med;
386(7): 629-639, 2022 02 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34904798
3.
Interim PET-guided treatment for early-stage NLPHL: a subgroup analysis of the randomized GHSG HD16 and HD17 studies.
Blood;
142(6): 553-560, 2023 08 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37257195
4.
GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany.
Blood;
140(4): 349-358, 2022 07 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35316325
5.
Patterns of PET-positive residual tissue at interim restaging and risk of treatment failure in advanced-stage Hodgkin's lymphoma: an analysis of the randomized phase III HD18 trial by the German Hodgkin Study Group.
Eur J Nucl Med Mol Imaging;
51(2): 490-495, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37735258
6.
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy.
Eur J Nucl Med Mol Imaging;
51(5): 1361-1370, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38114616
7.
Long-term remission in a patient with relapsed Richter's transformation treated with CD19-directed chimeric antigen-receptor T-cells after allogeneic stem cell transplantation.
Eur J Haematol;
112(6): 984-987, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38316549
8.
Noninvasive minimal residual disease assessment in relapsed/refractory large B-cell lymphoma using digital droplet PCR.
Eur J Haematol;
112(6): 957-963, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38369814
9.
Low B-cell content is associated with a CD73-low tumour microenvironment and unfavourable prognosis in classic Hodgkin lymphoma.
Br J Haematol;
201(6): 1097-1102, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36921595
10.
The new German evidence-based guideline on diffuse large B-cell lymphoma-key aspects for radiation oncologists.
Strahlenther Onkol;
199(2): 115-120, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36598520
11.
B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma.
Haematologica;
108(12): 3347-3358, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37139600
12.
Characteristics and outcomes of patients undergoing high-dose chemotherapy and autologous stem cell transplantation admitted to the intensive care unit: a single-center retrospective analysis.
Ann Hematol;
102(1): 191-197, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36394583
13.
Prognostic value of baseline metabolic tumor volume (MTV) for forecasting chemotherapy outcome in early-stage unfavorable Hodgkin lymphoma: Data from the phase III HD17 trial.
Eur J Haematol;
111(6): 881-887, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37644732
14.
Web-Based Cognitive-Behavioral Therapy to Reduce Severe Cancer-Related Fatigue Among Survivors of Hodgkin Lymphoma: A Feasibility Study.
J Clin Psychol Med Settings;
30(4): 856-865, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36808045
15.
Tumour cell characteristics and microenvironment composition correspond to clinical presentation in newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma.
Br J Haematol;
199(3): 382-391, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35880396
16.
Histopathological growth patterns in patients with advanced nodular lymphocyte-predominant Hodgkin lymphoma treated within the randomized HD18 study: a report from the German Hodgkin Study Group.
Br J Haematol;
196(1): 99-104, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34396513
17.
9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial.
Br J Haematol;
196(1): 116-126, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34520052
18.
Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i).
Br J Haematol;
196(3): 606-616, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34775591
19.
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
N Engl J Med;
380(1): 45-56, 2019 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30501490
20.
Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1.
Blood;
136(25): 2851-2863, 2020 12 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33113552